These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8931967)
21. [Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology]. Sibony M; Vieillefond A Ann Pathol; 2008 Oct; 28(5):381-401. PubMed ID: 19068393 [TBL] [Abstract][Full Text] [Related]
22. [Carcinoma and oncocytoma of the kidney. Phenotypic characteristics and prognostic features]. Störkel S Veroff Pathol; 1993; 140():1-165. PubMed ID: 8434485 [TBL] [Abstract][Full Text] [Related]
23. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Glukhova L; Lavialle C; Fauvet D; Chudoba I; Danglot G; Angevin E; Bernheim A; Goguel AF Oncogene; 2000 Feb; 19(6):754-61. PubMed ID: 10698493 [TBL] [Abstract][Full Text] [Related]
24. Urothelial carcinoma of the renal pelvis with choriocarcinomatous features: genetic evidence of clonal evolution. Zettl A; Konrad MA; Polzin S; Ehsan A; Riedmiller H; Müller-Hermelink HK; Ott G Hum Pathol; 2002 Dec; 33(12):1234-7. PubMed ID: 12514793 [TBL] [Abstract][Full Text] [Related]
26. Trisomy 3 in renal cell carcinoma. Renshaw AA; Fletcher JA Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314 [TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062 [TBL] [Abstract][Full Text] [Related]
28. Familial papillary renal carcinoma: cytogenetic characterization in normal and tumor tissues in two brothers. A case report. Gallucci M; Vico E; Sentinelli S; Leonardo C; Visca P; Orlandi G; Cianciulli A Urol Oncol; 2008; 26(3):295-8. PubMed ID: 18452823 [TBL] [Abstract][Full Text] [Related]
29. [Collecting duct (Bellini) carcinoma]. de Pablo Cárdenas A; Pinós Paul MA; Jiménez Aristu JI; Jiménez Calvo JM; Lozano Uruñuela F; Rivas Alonso A; Santiago González de Garibay AM; Guarch Troyas R Arch Esp Urol; 2004 Mar; 57(2):153-6. PubMed ID: 15074786 [TBL] [Abstract][Full Text] [Related]
31. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas. Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305 [TBL] [Abstract][Full Text] [Related]
33. Association of a renal papillary carcinoma with a low grade tumour of the collecting ducts. Daniel L; Zattara-Cannoni H; Lechevallier E; Pellissier JF J Clin Pathol; 2001 Aug; 54(8):637-9. PubMed ID: 11477121 [TBL] [Abstract][Full Text] [Related]
34. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306 [TBL] [Abstract][Full Text] [Related]
35. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus. Teyssier JR; Henry I; Dozier C; Ferre D; Adnet JJ; Pluot M J Natl Cancer Inst; 1986 Dec; 77(6):1187-95. PubMed ID: 3467112 [TBL] [Abstract][Full Text] [Related]
37. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424 [TBL] [Abstract][Full Text] [Related]
38. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478 [TBL] [Abstract][Full Text] [Related]
39. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319 [TBL] [Abstract][Full Text] [Related]